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Abstract
Apoptosis has revealed an essential function in the development or prevention of
oncogenic transformation in the body; however, programmed cell death (PCD) must
be tightly controlled since deregulated cell death is involved in the development of a
large number of different pathologies. Apoptosis can be decreased in pathological
states such as in cancer and autoimmunity or elevated such as in stroke,
neurodegeneration, retinal cell death, myocardial and liver ischemia, inflammatory
diseases such as sepsis, osteoarthritis (OA), rheumatoid arthritis (RA), and asthma.
Different types of apoptotic inhibitors will be discussed in this chapter displaying
their mechanism of action, which have been reported to be therapeutic targets for cell
survival or at least limiting cell death. These inhibitors are classified according to their
nature into natural antiapoptotic proteins that present mainly in the cell and synthetic
small molecule inhibitors that are widely used to protect against overexpression of
apoptosis mediators and, in turn, to prevent corresponding diseases.
Keywords: antiapoptosis, mechanism, apoptotic inhibitors, endogenous,
synthetic, cell survival
1. Introduction
Apoptosis is a crucial normal biological process that occurs in the cell as a
component of animal development, tissue hemostasis, and immune response. In
pathological state, it can be abrogated as in cancer and autoimmune diseases, or
over-expressed as in case of stroke, ischemia, psoriasis, and inflammatory diseases.
The apoptotic mechanism occurs through either extrinsic pathway or intrinsic
pathway, which leads to cell death through different apoptotic cascades, according
to the type of stimuli [1].
These cell survival strategies involve a myriad of coordinated and systematic
physiological and genetic changes that serve to ward off death [2].
There are various inhibitors of these pathways, which have been reported to be
helpful in inhibition of the cell death or limiting it. These inhibitors are classified
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according to their nature into endogenous antiapoptotic proteins that present
mainly in the cell to regulate the apoptosis process and synthetic inhibitors that are
synthesized to be used in case of overexpression of apoptosis mediators as in some
diseases.
1.1 Endogenous antiapoptotic inhibitors
1.1.1 Reduction in the number of apoptotic cells
It was reported that Ginkgo biloba extract (EGb 761) exhibited antiapoptotic
effect on different cell types [3], and it particularly inhibits death in human
lymphocytes when exposed to gossypol, a toxin that causes cell death via apoptosis.
Similar results have been observed in thymus cells pretreated with EGb 761 and
then exposed to ferrous sulfate in hydrogen peroxide (H2O2) [4]. Lymphocytes
that are isolated from spleen of aged mice and treated with EGb 761 were less
susceptible to reactive oxygen species (ROS)-induced apoptosis [5]. Scientists
revealed that the posttreatment with EGb 761 in the peripheral nervous system
decreased efficiently the number of apoptotic cells in injured rat spinal cord [6].
Moreover, it helps in treatment of the central nervous system reduced neuronal
death in the substantia nigra pars compacta from an experimental model of
Parkinson’s disease [7].
1.1.2 Maintaining the mitochondrial integrity
Rhodiola crenulata extract (RCE) is an edible alcohol extract, conserving greatly
the mitochondrial integrity and in turn prohibiting the release of cytochrome C,
which leads to cell death. The effective concentration of the most important com-
ponent, salidroside, was 4% (w/w).
Other herbals mediate its antiapoptotic effect through the same mechanism as
they possess a potent reactive oxygen species scavenging function; however, they
restore the mitochondrial membrane potential [8, 9].
Some drugs were tested in sympathoadrenal cells that showed obviously another
antiapoptotic pathway through inducing the antiapoptotic protein B-cell lymphoma
2 (Bcl-2) transcription rate and B-cell lymphoma-extra-large (Bcl-xL) proteins. The
role of these proteins appears crucial, because inhibition of their production by
antisense oligonucleotides (directed toward the translation initiation site of the
Bcl-2 transcript) resulted in aboliting protective effect. The prosurvival pathway
also included activation of the transcription nuclear factors NF-κB (a protein com-
plex that controls transcription of DNA, cytokine production, and cell survival) and
CREB (cellular transcription factor). It binds to certain DNA sequences and the
antiapoptotic kinase PKCα/β such as dehydroepiandrosterone (DHEAS) and
Allo [10].
1.1.3 Decrease in caspase transcription rate and DNA fragmentation
Some natural component reverse such as diosmin induces Bad and Bax, pro-
apoptotic members of the Bcl-2 family, to react with the mitochondrial membrane
and prevent the release of apoptotic-inducing factor (AIF) and cytochrome-C.
Cytochrome-C in turn inhibits initiator caspase-9, which prevents sequential
cascade of activation of caspase-3, and conserves DNA fragment along with no
apoptotic cell death [11].
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1.2 Synthetic apoptotic inhibitors
1.2.1 Tumor necrotic factor (TNF) inhibitors
Infliximab (IFX) [12], etanercept (ETN) [13], Adalimumab (ADA), golimumab
(GOLI) [14], and certolizumab pegol (CZP) [15] are clinical biologic drugs that act
as necrotic factor (TNF)-α inhibitors that were approved by the U.S. Food and Drug
Administration (FDA). Other synthetic TNF inhibitors were designed such as:
Compound (1) inhibited the release of TNF in cells and in animals. It was active
in a chronic rheumatoid arthritis model (MCIA) when administrated orally and it
was advanced for further preclinical evaluation [16]. A novel thalidomide analog
was synthesized and characterized for anti-TNF-α activity with up to a 38% inhibi-
tion for compound (2) with no obvious concentration dependence [17].
Compound (3) is an oleanolic acid analog, characterized by structural modifica-
tions at position C-3 and C-28 of oleanane skeleton and tested for anti-inflammatory
potential, when C-3 became Indole, and C-28 = cyclohexamine, gave mild inhibition
by 51.9% [18]. Compound (4) suppressed serum TNF-α levels by 2.45 ng/ml com-
pared to the control group 5.61 ng/ml [19].
Compound (5) possessed TNF inhibition with half-maximal inhibitory concen-
tration (IC50) = 0.5 μm [19]. Besides, Compound (6) decreased the level of the pro-
inflammatory cytokine TNF-α by (39.19%) [20].
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Compound (7) had 56% inhibition of TNF-α at 10 μm [21]. Betulinic acid (8)
had a significant decrease in IL1β, IL6, and TNFα in the neuronal tissues [22].
1.2.2 Fatty acid synthase (Fas) inhibitors
KR-33493 (9)was used as a potent inhibitor for ischemia Fas-mediated cell death 68
[23]. Compound (10a, b) RKTS-33,34 with 10 μmED50 value (concentration causing
50% of maximum effect) selectively inhibited apoptosis induced by FasL as well as
ECH (epoxycyclohexenone derivative) (11), which is produced by fungus [24].
Glycine (12) was tested as a cytoprotector against ischemic damage by
downregulation of FasL/Fas and caspase3 and upregulation of Bcl2 and Bcl2-bax
(apoptosis regulator BAX) [25]. Compound (13) was designed as a novel class of
ischemic cell death inhibitors targeting Fas-mediated cell death pathway with
EC50 = 0.557 μm (the concentration of a drug that gives half-maximal response), and
cell survival = 92.98% at 10 μm [26]. It was found that (dichlorovinyl dimethyl
phosphate) DDVP (14) significantly decreased the expression of Fas antigen on YAC-
1S target cells and the expression of FasL (Fas ligand) on LAK cells (lymphokine-
activated killer cell). These findings provided direct evidences that DDVP impaired
the FasL/Fas pathway via downregulating the expression of both Fas and FasL [27].
Geldanamycin (15), which was originally discovered in Streptomyces hygroscopicus
[28], inhibited Fas signaling pathway and protected neurons against ischemia [29].
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Compound (16) is the active form of vitamin D that inhibited Fas ligand-
induced apoptosis in human osteoblasts by regulating components of both the
mitochondrial and Fas-related pathways [30]. Estrogen (17) also inhibited Fas-
mediated apoptosis in experimental stroke [31].
Cilazapril (18) acts as an angiotensin-converting enzyme inhibitor along with
protection against apoptosis through downregulating Fas protein during the induc-
tion of apoptosis in cardiomyocytes in rat hearts when subjected to reperfusion after
ischemia [32]. M50054 (19) (cell-permeable inhibitor of the activation of caspase-3)
inhibited apoptosis induced by a variety of apoptotic stimuli such as the Fas/Fas
ligand system and etoposide. Thus, it might be effective for hepatitis when adminis-
tered orally and chemotherapy-induced alopecia when administered topically [33].
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SC79 (20) (AKT activator) prevented acute hepatic failure induced by Fas-
mediated apoptosis of hepatocytes [34]. Vit K2 (21) significantly suppressed both
Fas expression and Fas-mediated apoptosis of the cells in a dose-dependent fashion.
The maximum effect was observed when 6–10 mol/L of vitamin K2 was added to
the culture, a concentration comparable to that attained during therapy with vita-
min K2 [35].
Vanillic acid (22) inhibited Fas-receptor and caspase-mediated apoptosis
signaling pathway and so acted as cardioprotective [36]. NCX-1000 (NO-
releasing derivative of ursodeoxycholic acid) (23) is a nitric oxide (NO) derivative
of ursodeoxycholic acid (UDCA). When an NO-releasing moiety is added to UDCA,
the effectiveness in preventing Fas-mediated liver injury increased [37].
1.2.3 BH3 interacting-domain death agonist (BID) inhibitors
BID plays a central role in the apoptotic machinery mediating cytochrome C and
SMAC/DIABLO (mitochondrial protein that potentiates some forms of apoptosis)
released from mitochondria, a crucial event for caspase activation and cell death
[38]. Pharmacological inhibition of BID could therefore provide a protective benefit
against pathological cell death, occurring in cerebral ischemia [39], neurodegenera-
tive diseases [40, 41], liver inflammation [42], or other illnesses where BID has
been implicated [43].
BI-6C9 (24) was effective in inhibiting the carboxyl-terminal fragment (tBid)
(truncated protein) association with isolated mitochondria at 20 μm [39]. TC9-305
(2-sulfonyl-pyrimidinyl derivatives) (25) had an EC50 = 0.23 nm [44]. BI-11A7 (26)
was much more effective in this assay when compared with BI-6C9 (24) but
showed some toxicity at higher concentrations (20 μm) [45]. 3-o-tolylthiazolidine-
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2,4-dione (27) protected neural cells against glutamate- and tBid-induced toxicity
with an EC50 = 6.78 μm [46].
1.2.4 Tumor necrosis factor-like weak inducer of apoptosis (TWEAK) inhibitors
TWEAK also known as (Apo3L or TNFSF12) was first described as an inducer of
apoptosis in transformed cell lines [47]. It is a member of the tumor necrosis factor
(TNF) receptor family that is induced in a variety of cell types in situations of tissue
injury. It is a crucial player in muscle atrophy, cerebral ischemia, kidney injury,
atherosclerosis, and infarction, as well as in various autoimmune scenarios includ-
ing experimental autoimmune encephalitis, rheumatoid arthritis, and inflammatory
bowel disease [48]. Aurintricarboxylic acid (ATA) (28) was a potent inhibitor of
the TWEAK-Fn14 signaling axis and could potentially be utilized to enhance the
therapeutic response in glioblastoma (GBM) [49]. L524-0366 (29) was a specific
dose-dependent inhibitor of TWEAK-Fn14 interaction [50] and it was found to be a
complete suppressor for TWEAK-induced T98G cell migration at dose equal to
10 μm [51].
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1.2.5 Cytochrome C inhibitors
Cytochrome C is the specific and efficient electron transfer mediator between
the two last redox complexes of the mitochondrial respiratory chain [52]. The
release of cytochrome C from the mitochondria into the cytoplasm results in
caspase-9 activation leading to cell death [43]. Minocycline (30) directly inhibited
the release of cytochrome C from mitochondria. Therefore, it was beneficial in
experimental models of stroke, traumatic brain and spinal cord injury, Huntington’s
disease (HD), amyotrophic lateral sclerosis (ALS), Parkinson’s disease, and multiple
sclerosis [53, 54]. Methazolamide (31) was FDA approved for the treatment of
glaucoma, while melatonin (32) inhibited oxygen/glucose deprivation—induced
cell death, loss of mitochondrial membrane potential, release of mitochondrial
factors, pro-IL-1β processing, and activation of caspase-1 and -3 in primary
cerebrocortical neurons. Furthermore, compounds (32, 33) decreased infarct size
and improved neurological scores after middle cerebral artery occlusion in mice
[54–56]. Gamma-tocotrienol (GTT) (33) had the antiapoptotic effects by
preventing the activation of caspase-3 and caspase-9, reducing the release of cyto-
chrome C from the mitochondria and preventing H2O2-induced apoptosis in human
diploid fibroblasts (HDFs), and delayed cellular aging [57].
3-hydroxypropyl-triphenylphosphonium (TPP)-conjugated imidazole-
substituted oleic acid (TPP-IOA(34a)) and stearic acid (TPP-ISA(34b)) exerted
strong specific liganding of heme-iron in cytochrome C/cardiolipin (CL) complex
and effectively suppressed its peroxidase activity and CL peroxidation, thus
preventing cytochrome C release and cell death, and protecting mice against lethal
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doses of irradiation [58, 59]. TPP-6-ISA (35) was an effective inhibitor of the
peroxidase function of cyt c/CL complexes with a significant antiapoptotic activity
that realized in mouse embryonic cells exposed to ionizing irradiation [60, 61].
1.2.6 P53 upregulated modulator of apoptosis (PUMA) inhibitors
It is a Bcl-2 homology 3 (BH3)-only Bcl-2 family member and a key mediator of
apoptosis induced by a wide variety of stimuli 106. PUMA inhibitors may provide
radiation protection and mitigation, there were three compounds that had a strong
PUMA inhibition and that were designed by Gabriela Mustata et al., and data were
not published due to intellectual property protection [62].
CLZ-8 (36) was capable of targeting a PUMA protein and has very good physi-
cochemical properties, very good apoptosis resistance, and radiation protection
effects. It was found to protect cells from DNA damage under the concentration of
1 μm [63].
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1.2.7 Bax inhibitors
Xanthan gum (XG) (37) is an extracellular polysaccharide secreted by microor-
ganisms and was first discovered during fermentation process using Xanthomonas
campestris. It could protect subchondral trabecular in bone subchondral, decrease
the apoptosis of chondrocytes, downregulate the expressions of active caspase-9,
active caspase-3 and bax, and upregulate the expression of bcl-2. Lower range of
molecular weight of xanthan gum (LRWXG) could upregulate the expression of
cytochrome C in mitochondria while downregulating the expression of cytochrome
C in cytoplasm. These findings showed that LRWXG could inhibit cartilage degra-
dation via an intrinsic bax-mitochondria cytochrome C-caspase pathway [64].
PD98059 (38) showed inhibition of staurosporine-, UV-, anticancer drug-
induced apoptosis in vitro and protected brain against cell death through inhibition
of BAX and other factors [65, 66]. Vitamin E (39) significantly reduced the effects
of gentamicin on BAX and BCL-2 expression levels [67].
Tanshinone (40) could inhibit the expression of Bax and stimulated the expres-
sion of Bcl-2 in cardiomyocytes in the ischemia-reperfusion rat model [68].
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2. Conclusion
Apoptotic inhibitors regulate cell proliferation by promoting cell survival. One
promising area of research that has been covered extensively in this review is
displaying the recent developed apoptotic inhibitors and their significance to func-
tional therapies for a number of diseases and pathophysiologies. These inhibitors are
working through numerous built-in avenues’ mechanisms, including inhibition of
pro-apoptotic and apoptotic factors. Our perspectives are to develop new therapeu-
tic strategies aiming to participate in treatment of serious diseases such as stroke,
neurodegeneration, retinal cell death, myocardial and liver ischemia, sepsis, osteo-
arthritis (OA), rheumatoid arthritis (RA), and asthma or to reduce the adverse
effects accompanied with long-term therapy of cancer and autoimmunity. Hope-
fully, scientists will soon be able to provide every patient suffering from imbalanced
apoptotic disease with a more specified and suitable therapy.
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